GSI Technology Announces Production Release of Two Gemini-I® APU Servers
SUNNYVALE, Calif., April 02, 2024 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit […]
NeoVolta’s NV-14 Home Battery Named Solar Power World Top Solar Storage Products for 5th Consecutive Year
SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) — (NASDAQ: NEOV) – NeoVolta Inc., a San-Diego based leader in Smart Energy […]
Scale Computing Approved on Climb Channel Solutions’ OMNIA Partners/NCPA and GSA Contracts
EATONTOWN, N.J., April 02, 2024 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary […]
Qifu Technology Provides Updates on Share Repurchase Plans
SHANGHAI, China, April 02, 2024 (GLOBE NEWSWIRE) — Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), […]
Robin Harries assumes CFO role at trivago
DÜSSELDORF, Germany, April 2 – trivago N.V. (NASDAQ: TRVG) today announced the completion of its leadership change with the arrival […]
Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
SOUTH SAN FRANCISCO, Calif., April 02, 2024 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a […]
RadNet Announces Outpatient Radiology Partnership with Providence Health System to Include Seven Centers in Burbank, Santa Clarita and the Northern San Fernando Valley of Los Angeles
LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, fixed-site outpatient […]
Canoo Enters a $30 Billion Market with Multiple Commercial Vehicle Sales in Saudi Arabia
Justin, TX and Riyadh, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) — Canoo Inc. (NASDAQ: GOEV), a leading high-tech advanced […]
Cnova N.V. : Acquisition of Predominant Control over Cnova
Financial Restructuring of Casino Group Results in Change of Control over Cnova AMSTERDAM – April 2, 2024, 08:15 CET Cnova […]
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Endometrial Cancer with Priority Review Status
— NDA accepted and both fruquintinib and sintilimab granted Priority Review, following Breakthrough Therapy designation in July 2023 — — First […]
